Refine by
Sars Cov 2 Suppliers Serving Tonga
10 companies found
Technologybased inVancouver, CANADA
SaNOtize Research and Development Corp., is a rapidly growing pharmaceutical company focused on developing and commercializing high quality, innovative products. We aim to improve the quality of life for people throughout the world by using our ...
Technologybased inSALUGGIA, ITALY
We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years we have been dealing with diagnostics to help physicians and patients make better decisions in the ...
DiaSorin strives to improve health-care around the globe through the development of innovative diagnostic solutions that can lead to better patient outcomes and provide economic benefits to the healthcare system. Thanks to its team of dedicated ...
Technologybased inDallas, TEXAS (USA)
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology ...
Employs a “multitope” approach to neutralizing the SARS-CoV-2 virus, eliciting a well-balanced B and T-cell response against multiple viral epitopes. Phase 1 and Phase 2 ...
Technologybased inMelbourne, AUSTRALIA
Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and ...
Further, VivaGel® has been shown, in laboratory studies, to have broad-spectrum and potent antiviral activity against a wide range of viruses, including HIV, herpes simplex, hepatitis B, HPV, Zika, adenovirus, RSV and ...
Technologybased inShanghai, CHINA
Tellgen Corporation was established in 2003 at the Medicine Valley in Shanghai, also known as the Silicon Valley of China, which is the first to develop reagents based on Luminex Platforms. Went public in 2017 in Shenzhen and grew to 1000 employees. ...
SARS-CoV-2 IgM Antibody Detection Kit based on Chemiluminescence Immunoassay ...
Technologybased inNangang Distric, TAIWAN
We are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ...
Studies by X. Yao et al and S. Perinel et al suggest that HCQ can prevent the acidification of intracellular organelles, inhibit lysosomal release of viral genome and interfere with the glycosylation of the angiotensin-converting enzyme-2 (ACE2) ...
Technologybased inAbingdon, UNITED KINGDOM
Thermally Stable Needle Free Solid Dose Vaccines. Enesi Pharma is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies. These diseases affect millions of ...
The COVID-19 global health emergency has highlighted the need for vaccines to address novel infections, as its rapid spread has made vaccine development an urgent worldwide priority. While speed is of the essence, both scientific considerations for ...
Technologybased inVancouver, BRITISH COLUMBIA (CANADA)
Ondine Biomedical Inc. is a Canadian life sciences company that has become a global leader in photodisinfection-based therapies to prevent and treat a broad spectrum of infections, including those caused by drug-resistant pathogens. This patented ...
While most research efforts towards treating and preventing COVID-19 have centered on vaccine development and therapies for hospitalized patients, Ondine is seeking to offer a therapeutic approach to those patients who test positive but are not yet ...
Technologybased inNew Orleans, LOUISIANA (USA)
Our mission is to advance infectious disease diagnosis and improve patient care using novel diagnostic platforms that produces rapid and accurate results from patient samples. Our versatile platforms address critical needs for current infectious ...
To address these issues, NanoPin uses an antibody enrichment approach to capture species-specific biomarker peptides released upon trypsin digestion of the serum of infected individuals and employs mass spectrometry to identify these peptides with ...
Technologybased inFramingham, MASSACHUSETTS (USA)
Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...
The COVI-QUANT™ test will give you an answer. It represents the latest generation of testing technology that will provide a numerical value for your antibody level, not just yes or no. COVI-QUANT™ is an ELISA test available through ...